Final results from a phase III trial evaluating panitumumab (pmab) plus best supportive care (BSC) vs BSC in chemorefractory wild-type (WT) KRAS exon 2 and WT RAS metastatic colorectal cancer (mCRC).

Results

Title:	Final results from a phase III trial evaluating panitumumab (pmab) plus best supportive care (BSC) vs BSC in chemorefractory wild-type (WT) KRAS exon 2 and WT RAS metastatic colorectal cancer (mCRC).
Authors :	Kim, Tae Won; ...; Kusic, Zvonko; ...; Manojlović, Nebojša S. ; ...; (broj, koautora 16)
Issue Date:	2016
Publication:	JOURNAL OF CLINICAL ONCOLOGY
ISSN:	0732-183X e1527-7755 Journal of Clinical Oncology Search Idenfier
Publisher:	Lippincott Williams & Wilkins
Type:	Conference Paper
Collation:	vol. 34 br. 15 Suppl. S (Meeting Abstract 3536)
DOI:	10.1200/JCO.2016.34.15_suppl.3536
WoS-ID:	000404665404253
URI:	https://enauka.gov.rs/handle/123456789/820294
URL:	https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.3536
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Altmetric

Dimensions

Unpaywall

Google Scholar^TM